VINCRISTINE SULFATE INJECTION USP
VINCRISTINE SULFATE INJECTION USP
Approved
DIN Number
02183013
Drug Class
Human
Market Date
Aug 7, 1997
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02183013
AIG Number0107646001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CA02 VINCRISTINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
VINCRISTINE SULFATEActive
Strength: 1 MG / ML
Monograph: VINCRISTINE SULFATE